• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Efficacy and safety of injection Botulinum toxin in canalicular obstruction due to trauma.注射用肉毒杆菌毒素治疗外伤性泪小管阻塞的疗效与安全性。
Med J Armed Forces India. 2023 Sep-Oct;79(5):584-589. doi: 10.1016/j.mjafi.2021.09.007. Epub 2021 Nov 28.
2
Comparison of the efficacy and safety of lacrimal gland botulinum toxin injection in functional versus non-functional epiphora.泪腺注射肉毒杆菌毒素治疗功能性与非功能性溢泪的疗效及安全性比较
Cutan Ocul Toxicol. 2024 Dec;43(4):278-286. doi: 10.1080/15569527.2024.2402402. Epub 2024 Sep 17.
3
Outcomes of lacrimal gland injection of botulinum toxin in functional versus nonfunctional epiphora.功能性与非功能性溢泪患者泪腺注射肉毒杆菌毒素的疗效
Oman J Ophthalmol. 2019 May-Aug;12(2):104-107. doi: 10.4103/ojo.OJO_52_2018.
4
Comparison of botulinum toxin-A injection in lacrimal gland and conjunctivodacryocystorhinostomy for treatment of epiphora due to proximal lacrimal system obstruction.泪腺注射A型肉毒杆菌毒素与泪囊鼻腔吻合术治疗近端泪道系统阻塞所致溢泪的比较
Eye (Lond). 2016 Aug;30(8):1056-62. doi: 10.1038/eye.2016.88. Epub 2016 May 20.
5
Botulinum neurotoxin injection for the treatment of epiphora in nasolacrimal duct obstruction.肉毒杆菌神经毒素注射治疗鼻泪管阻塞所致溢泪症
J Fr Ophtalmol. 2017 Oct;40(8):661-665. doi: 10.1016/j.jfo.2017.03.006. Epub 2017 Aug 25.
6
Lacrimal gland botulinum toxin injection for epiphora management.泪腺肉毒杆菌毒素注射治疗溢泪。
Orbit. 2022 Apr;41(2):150-161. doi: 10.1080/01676830.2021.1966810. Epub 2021 Aug 15.
7
A review on use of botulinum toxin for intractable lacrimal drainage disorders.肉毒杆菌毒素用于治疗顽固性泪道疾病的综述。
Int Ophthalmol. 2018 Oct;38(5):2233-2238. doi: 10.1007/s10792-017-0661-9. Epub 2017 Aug 1.
8
Botulinum toxin for palliative treatment of epiphora in a patient with canalicular obstruction.肉毒杆菌毒素用于泪小管阻塞患者溢泪的姑息治疗。
Ophthalmology. 2005 Aug;112(8):1469-71. doi: 10.1016/j.ophtha.2005.02.022.
9
Botulinum neurotoxin A injection for the treatment of epiphora with patent lacrymal ducts.注射A型肉毒杆菌神经毒素治疗泪道通畅的溢泪症
J Fr Ophtalmol. 2018 Apr;41(4):343-349. doi: 10.1016/j.jfo.2017.11.010. Epub 2018 Apr 19.
10
Repeated injections of botulinum toxin-A for epiphora in lacrimal drainage disorders: qualitative and quantitative assessment.肉毒杆菌毒素-A 治疗溢泪症的重复注射:定性和定量评估。
Eye (Lond). 2019 Jun;33(6):995-999. doi: 10.1038/s41433-019-0362-x. Epub 2019 Feb 14.

引用本文的文献

1
Efficacy and safety of botulinum toxin as a non-surgical option for upper eyelid retraction in active thyroid-associated ophthalmopathy: a prospective interventional study.肉毒杆菌毒素作为活动性甲状腺相关性眼病上睑退缩非手术治疗选择的疗效和安全性:一项前瞻性干预研究。
Int Ophthalmol. 2025 Jul 15;45(1):293. doi: 10.1007/s10792-025-03658-4.
2
Surgical outcomes of external dacryocystorhinostomy with flap versus without flap in acquired nasolacrimal duct obstruction.有瓣与无瓣外路泪囊鼻腔吻合术治疗后天性鼻泪管阻塞的手术效果
Indian J Ophthalmol. 2024 Nov 1;72(11):1670-1672. doi: 10.4103/IJO.IJO_3379_23. Epub 2024 Oct 26.

本文引用的文献

1
Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial.经结膜与经皮注射肉毒杆菌毒素至泪腺以减少泪液分泌:一项随机对照试验
Toxins (Basel). 2021 Jan 21;13(2):77. doi: 10.3390/toxins13020077.
2
Repeated injections of botulinum toxin-A for epiphora in lacrimal drainage disorders: qualitative and quantitative assessment.肉毒杆菌毒素-A 治疗溢泪症的重复注射:定性和定量评估。
Eye (Lond). 2019 Jun;33(6):995-999. doi: 10.1038/s41433-019-0362-x. Epub 2019 Feb 14.
3
Botulinum neurotoxin injection for the treatment of epiphora in nasolacrimal duct obstruction.肉毒杆菌神经毒素注射治疗鼻泪管阻塞所致溢泪症
J Fr Ophtalmol. 2017 Oct;40(8):661-665. doi: 10.1016/j.jfo.2017.03.006. Epub 2017 Aug 25.
4
A review on use of botulinum toxin for intractable lacrimal drainage disorders.肉毒杆菌毒素用于治疗顽固性泪道疾病的综述。
Int Ophthalmol. 2018 Oct;38(5):2233-2238. doi: 10.1007/s10792-017-0661-9. Epub 2017 Aug 1.
5
Assessment of patient-reported outcome and quality of life improvement following surgery for epiphora.泪溢手术后患者报告结局及生活质量改善情况的评估
Eye (Lond). 2017 Dec;31(12):1664-1671. doi: 10.1038/eye.2017.120. Epub 2017 Jun 16.
6
Comparison of botulinum toxin-A injection in lacrimal gland and conjunctivodacryocystorhinostomy for treatment of epiphora due to proximal lacrimal system obstruction.泪腺注射A型肉毒杆菌毒素与泪囊鼻腔吻合术治疗近端泪道系统阻塞所致溢泪的比较
Eye (Lond). 2016 Aug;30(8):1056-62. doi: 10.1038/eye.2016.88. Epub 2016 May 20.
7
Botulinum toxin injection for the treatment of epiphora in lacrimal outflow obstruction.肉毒杆菌毒素注射治疗泪液引流阻塞所致的溢泪症
Eye (Lond). 2015 May;29(5):656-61. doi: 10.1038/eye.2015.18. Epub 2015 Mar 6.
8
Results of lacrimal gland botulinum toxin injection for epiphora in lacrimal obstruction and gustatory tearing.泪腺注射肉毒毒素治疗泪道阻塞和味觉性流泪的疗效。
Ophthalmic Plast Reconstr Surg. 2011 Mar-Apr;27(2):119-21. doi: 10.1097/IOP.0b013e318201d1d3.
9
Transconjunctival botulinum toxin offers an effective, safe and repeatable method to treat gustatory lacrimation.经结膜肉毒杆菌毒素提供了一种有效、安全且可重复的方法来治疗味觉性流泪。
Br J Ophthalmol. 2010 Mar;94(3):379-80. doi: 10.1136/bjo.2008.155887.
10
Conjunctivodacryocystorhinostomy with the frosted jones pyrex tube.带磨砂琼斯派热克斯玻璃管的结膜泪囊鼻腔造口术
Ophthalmic Plast Reconstr Surg. 2009 Jan-Feb;25(1):42-3. doi: 10.1097/IOP.0b013e3181911d13.

注射用肉毒杆菌毒素治疗外伤性泪小管阻塞的疗效与安全性。

Efficacy and safety of injection Botulinum toxin in canalicular obstruction due to trauma.

作者信息

Vinay Kumar Sonali, Kumar Vinay, Mishra Sanjay, Sati Alok

机构信息

Associate Professor (Ophthalmology), Army Hospital (R&R), Delhi Cantt, India.

Professor & Head (Anatomy), World College of Medical Sciences Research & Hospital, Jhajjar, Haryana, India.

出版信息

Med J Armed Forces India. 2023 Sep-Oct;79(5):584-589. doi: 10.1016/j.mjafi.2021.09.007. Epub 2021 Nov 28.

DOI:10.1016/j.mjafi.2021.09.007
PMID:37719907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10499646/
Abstract

BACKGROUND

The treatment of epiphora has undergone tremendous change in the past, and minimally invasive techniques are being preferred over traditional surgical options. One of them is the use of Inj Botulinum toxin, but there are very few studies that have explored its role in treating post-traumatic epiphora. This study was undertaken to find out the safety and efficacy of injection Botulinum toxin in treating epiphora due to canalicular obstruction following trauma.

METHODS

A longitudinal interventional study was done, and a total of 50 patients were recruited. All patients were subjected to Inj Botulinum toxin in the lacrimal gland (10 units). The study was done for a period of 6 months, and patients were followed up for a period of another 6 months. Changes in Munk score, Schirmer test, and tear meniscus height were considered the main outcome measures.

RESULTS

In our study, there were 38 males and 12 females. The age of the patients varied from 24 yrs to 67 yrs. Inj Botulinum toxin was found to be effective in 80% (n = 40/50) of cases as they reported a reduction in watering from eyes after administration of this injection. The complication associated with this treatment was minimal in our study as four patients reported diplopia, whereas two patients developed Ptosis that resolved spontaneously within two months.

CONCLUSION

Inj Botulinum toxin was found to be effective in epiphora caused by canalicular obstruction due to trauma. This treatment should be considered as an alternative treatment modality as it often leads to satisfactory reduction in epiphora in patients with less complications compared to surgical intervention.

摘要

背景

过去泪溢的治疗方法发生了巨大变化,微创技术比传统手术选择更受青睐。其中之一是使用注射用肉毒杆菌毒素,但很少有研究探讨其在治疗创伤后泪溢中的作用。本研究旨在探讨注射用肉毒杆菌毒素治疗外伤后泪小管阻塞所致泪溢的安全性和有效性。

方法

进行了一项纵向干预研究,共招募了50名患者。所有患者均在泪腺注射肉毒杆菌毒素(10单位)。研究为期6个月,患者随后又接受了6个月的随访。主要观察指标为蒙克评分、泪液分泌试验和泪膜高度的变化。

结果

在我们的研究中,男性38例,女性12例。患者年龄在24岁至67岁之间。发现注射用肉毒杆菌毒素在80%(n = 40/50)的病例中有效,因为他们报告注射后眼部分泌物减少。在我们的研究中,与这种治疗相关的并发症很少,有4例患者报告出现复视,而2例患者出现上睑下垂,在两个月内自行缓解。

结论

发现注射用肉毒杆菌毒素对外伤性泪小管阻塞所致泪溢有效。这种治疗应被视为一种替代治疗方式,因为与手术干预相比,它通常能使泪溢患者得到满意的缓解,且并发症较少。